Medication info
Rozerowong 10/20 milligrams

Rozerowong 10/20 milligrams

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium›20.8mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
Samchundang Pharmaceutical Co., Ltd.
Appearance
White to almost white round film-coated tablets
Packaging
30 tablets (15 tablets/PTP × 2)
Approval status
Active

MFDS item code 201606042 · Approved 2016.10.12 · Insurance code 651204860

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
This medicine should be administered once daily, regardless of meals. Patients should continue a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range is 10/5 mg to 10/20 mg once daily. The recommended starting dose is 10/5 mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly; it may be increased up to a maximum of 10/20 mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience.

Ingredients

Manufacturer
Samchundang Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated Apo B protein
  • elevated triglycerides
  • elevated non-HDL cholesterol
  • increased risk of atherosclerotic vascular disease due to hypercholesterolemia
  • dyslipidemia
  • diabetes
View approved original text

This medication is used to lower the levels of total cholesterol, LDL cholesterol, Apo B protein, triglycerides, and non-HDL cholesterol in patients with primary hypercholesterolemia and mixed dyslipidemia, while increasing HDL cholesterol levels. It is particularly administered as an adjunct to dietary measures in patients with increased risk of atherosclerotic vascular disease due to hypercholesterolemia to control lipid levels. It is used when adequate dietary measures and other non-pharmacological treatments are insufficient, and it is important to first identify and treat any secondary causes, such as diabetes or hypothyroidism, if necessary. Moreover, during treatment, total cholesterol, as well as LDL, HDL cholesterol, and triglyceride levels should be regularly monitored to ensure management. This helps to improve blood lipid abnormalities and thereby reduce the risk of cardiovascular disease.

How to take

Adult dose

This medicine should be administered once daily, regardless of meals. Patients should continue a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range is 10/5 mg to 10/20 mg once daily. The recommended starting dose is 10/5 mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly; it may be increased up to a maximum of 10/20 mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience.

Precautions

This medication has been reported to cause rare but serious muscular problems. If severe muscle pain or weakness symptoms occur, it is essential to consult a physician immediately. This medication should not be administered to patients with impaired liver function or certain muscle disorders. It should also not be used in patients with severely impaired kidney function, or in pregnant or breastfeeding women. Patients with a history of alcohol dependence or liver disease, elderly patients, and those with hypothyroidism should exercise extra caution while using this medication. Patients at high risk of myopathy should have their muscle enzyme levels checked thoroughly before and during treatment. During the use of this medication, regular liver function tests should be conducted, and if any abnormal symptoms regarding the liver appear, the use of the medication should be discontinued immediately. Additionally, this medication can interact with other drugs, so if there are any currently taken medications, it is imperative to inform the physician or pharmacist. Special caution is needed when combined with drugs that affect blood coagulation, certain antibiotics, antifungals, and immunosuppressants. Women of childbearing potential should use appropriate contraceptive methods while taking this medication, and if pregnancy is confirmed, the medication should be discontinued immediately. This medication has not been adequately studied for safety and efficacy in children; therefore, it is not recommended for use in the pediatric population. In the case of overdose, as there are no specific antidotes, appropriate treatment should be administered based on symptoms, and monitoring of liver function and muscle enzyme levels is necessary. Finally, this medication should be stored out of the reach of children and not transferred to other containers.

Side effects

Acute renal failure due to myoglobinuria, rhabdomyolysis, nasopharyngitis, arthralgia, headache, elevated ALT, elevated AST, myalgia, edema, increased serum bilirubin, acneiform dermatitis, pruritus, dizziness, upper respiratory infection, chest pain, facial edema, strange sensation, drug intolerance, colorectal polyp, irritable bowel syndrome, esophagitis, somnolence, neurodegenerative disorders, orthostatic dizziness, migraine, diabetes, glucose tolerance impairment, depression, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue infection, hepatic steatosis, liver disorders, hepatic toxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, increased blood cholesterol, increased serum alkaline phosphatase, arrhythmia, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, sweating, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory distress, pelvic pain, breast cysts, eyelid drooping, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, muscle weakness, headache, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myopathy, rhabdomyolysis, weakness, fatigue, numbness, paresthesia, chest discomfort, anorexia, abdominal bloating, syncope, generalized pain, muscle cramping, gout, erectile dysfunction, cough, dyspnea, diarrhea, thrombocytopenia, cholelithiasis, cholecystitis, tremor, epigastric pain, vomiting, gastritis, xerostomia, epigastric discomfort, belching, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, rhinorrhea, limb pain, arthralgia, anemia, splenomegaly, urticaria, hyperhidrosis, conjunctival injection, renal failure, liver dysfunction, increased serum creatinine, hypertension, increased blood urea, increased CPK, abnormal liver function tests

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. The recommended storage temperature is between 1 and 30 degrees Celsius. Proper storage conditions will help maintain the effectiveness of the medication.

Appearance and packaging

Appearance

White to almost white round film-coated tablets

Package unit

30 tablets (15 tablets/PTP × 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.